Skip to main content
. 2021 Jul 5;13(13):3376. doi: 10.3390/cancers13133376

Figure 1.

Figure 1

Representation of the “real-world” cohort of the study. (A) From an initial population of 161 patients, the histopathological review excluded samples without sufficient tumour cell content. Seventy tumour samples “gene driver free” and 55 MSI cases were eligible for RNA extraction and analysis, leading to a final cohort of 125 patients. (B) Final cohort composition: number of melanoma (MEL), colorectal cancer (CRC), and lung adenocarcinoma (LAC) patients according to gender, subdivided in “gene driver free”, and microsatellite instable (MSI) patients.